We have been serving for San Diego Biomedical research community since BioPioneer was founded in 2004. We will continue to strive our best to provide you with affordable products and quick delivery service.
Visit us at www.biopioneerinc.com to learn more about our products and services.
Crinetic Pharmaceuticals (founded and led by SDEE member Scott Struthers) was awarded a $2.2 million dollar Phase II Small Business Innovation Research Grant (SBIR) grant from the NIH to develop novel drugs for the treatment of pituitary tumors.Read more
Reveal Biosciences (founded by SDEE's Claire Weston) signed an agreement with Science Exchange (in partnership with antibodies-online.com) to independently validate commercial antibodies. The goal of the program is to improve research quality and reduce waste of resources by verifying high quality antibodies.Read more
Orphagen Pharmaceutical was awarded a $446,635 NIH National Center for Advancing Translational Sciences (NCATS) Phase I SBIR grant to Investigate Novel Small Molecules to treat Retina Pigmentosa (RP). SDEE member Scott Thacher, Orphagen's founder and CEO, is a Principal Investigator of the grant.Read more